Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Updownsidewayson Apr 07, 2017 11:32pm
345 Views
Post# 26095078

RE:How high can we get...

RE:How high can we get...Valuation is not about share price, but rather market cap. Due to the varying degree of shares outstanding for every different company, share price means nothing. At $20 a share, using current shares outstanding, gives ACB a valuation of almost 6.5 billion. That's a pretty big stretch on revenues. The entire Canadian MJ market is thought to be around 7 billion. So I don't think $10+ share price will be seen for at least 4-5 years. Let's get over 1 billion cap first. We'll need some serious revenues to justify even current valuation.

aurorahigh wrote: I agree on most price predictions. If they keep being a game player and advancer then $10 is not unreasonable in the short term.  ACB is always listed as top 3 contenders in their field yet pale in price comparison.  It's an easy $10.  Not if but when the US is fully onboard Canada has the advantage rightnow.  Real concern is competition but no reason this couldn't be a $20-$30 stock in time if they can keep up, which I think they can.  I'd prefer the company to buy back shares.  Most industries have major players all reaping profits,were positioned well with long term growth....I have time and patience...


Bullboard Posts